Table 1 List of autoimmune diseases and autoantibodies associated with SARS-CoV-2 infection
From: Effects of Cell Proteostasis Network on the Survival of SARS-CoV-2
Autoimmune disorder secondary to SARS-CoV-2 infection | Autoantibodies detected in COVID-19 patients |
|---|---|
Antiphospholipid syndrome | Antiphosphatidylserine IgM/IgG |
Immune thrombocytopaenic purpura | Anti-SSA autoantibody |
Guillain-Barré syndrome | Anti-globulin antibodies |
Cold agglutinin disease & autoimmune | Anti-nuclear antibodies (ANA) |
Systemic lupus erythematosus (SLE) | Anti-cardiolipin (aCL) antibodies |
Miler Fisher Syndrome (MFS) | Anti-MDA5 antibodies |
Kawasaki disease | Anti-β2 glycoprotein 1 antibodies |
NMDA-receptor encephalitis | LAC –lupus anticoagulant |
Subacute thyroiditis | Antiprothrombin IgM |
Graves’ disease | Anti-GD1b antibodies |
Sarcoidosis | Anti-CCP antibodies |
Myasthenia gravis | Anti-heparin PF4 complex antibody |
Hemolytic anemia | Antiannexin V IgM/IgG |
Neuromyelitis optica | pANCA AND cANCA |
Large vessel vasculitis & thrombosis | Â |
Type I diabetes | Â |
Psoriasis | Â |